Preparation and Characterization of Tetrandrine-phospholipid Complex Loaded Lipid Nanocapsules As Potential Oral Carriers

Overview

Journal Int J Nanomedicine

Publisher Dove Medical Press

Specialty Biotechnology

Date 2013 Nov 9

PMID 24204145

Citations 12

Authors

Yi-Qing Zhao

Li-Ping Wang

Chao Ma

Kun Zhao

Ying Liu

Nian-Ping Feng

Affiliations

Soon will be listed here.

Abstract

Background: Tetrandrine is an active constituent that is extracted from the root tuber of the Chinese herb Stephania tetrandra S. Moore. It has shown various pharmacological effects, such as antitumor activity, multidrug resistance reversal, and hepatic fibrosis resistance. In clinical applications, it has been used to treat hypertension, pneumosilicosis, and lung cancer. However, the poor water solubility of tetrandrine has limited its application. In this study, a newly emerging oral drug carrier of phospholipid complex loaded lipid nanocapsules was developed to improve the oral bioavailability of tetrandrine.

Methods: The phospholipid complex was prepared with the solvent-evaporation method to enhance the liposolubility of tetrandrine. The formation of the phospholipid complex was confirmed with a solubility study, infrared spectroscopy, and a differential scanning calorimetry (DSC) analysis. The tetrandrine-phospholipid complex loaded lipid nanocapsules (TPC-LNCs) were prepared using the phase inversion method. Lyophilization was performed with mannitol (10%) as a cryoprotectant. TPC-LNCs were characterized according to their particle size, zeta potential, encapsulation efficiency, morphology by transmission electron microscopy, and crystallinity by DSC. In addition, the in vitro release of tetrandrine from TPC-LNCs was examined to potentially illustrate the in vivo release behavior. The in vivo bioavailability of TPC-LNCs was studied and compared to tetrandrine tablets in rats.

Results: The liposolubility of tetrandrine in n-octanol improved from 8.34 μg/mL to 35.64 μg/mL in the tetrandrine-phospholipid complex. The prepared TPC-LNCs were spherical-shaped particles with a small size of 40 nm and a high encapsulation efficiency of 93.9%. DSC measurements revealed that the crystalline state was less ordered in lipid nanocapsules. The in vitro release study demonstrated a fast release of approximately 25% in the first 1 hour, which was followed by a sustained release of 70% over 12 hours. The relative bioavailability of TPC-LNCs compared to that of tablets was 208%, indicating a significant improvement in the oral absorption of tetrandrine.

Conclusion: The TPC-LNCs system developed in this study is a promising carrier that improves the oral bioavailability of tetrandrine in rats. The phospholipid complex loaded lipid nanocapsules have great potential for use as an oral drug delivery system for moderately lipophilic drugs that are encapsulated in the lipid nanocapsules.

Citing Articles

Tetrandrine for Targeting Therapy Resistance in Cancer.

Lima E, Lamichhane S, Bahadur K, Ferreira E, Koul S, Koul H Curr Top Med Chem. 2024; 24(12):1035-1049.

PMID: 38445699 PMC: 11259026. DOI: 10.2174/0115680266282360240222062032.

Preparation of Tetrandrine Nanocrystals by Microfluidic Method and Its In Vitro and In Vivo Evaluation.

Huang J, Huang S, Liu S, Feng L, Huang W, Wang Y AAPS PharmSciTech. 2023; 25(1):4.

PMID: 38114843 DOI: 10.1208/s12249-023-02718-1.

Progress on structural modification of Tetrandrine with wide range of pharmacological activities.

Mo L, Zhang F, Chen F, Xia L, Huang Y, Mo Y Front Pharmacol. 2022; 13:978600.

PMID: 36052124 PMC: 9424556. DOI: 10.3389/fphar.2022.978600.

Structurally nanoengineered antimicrobial peptide polymers: design, synthesis and biomedical applications.

Ramamurthy R, Mehta C, Nayak U World J Microbiol Biotechnol. 2021; 37(8):139.

PMID: 34278535 PMC: 8286942. DOI: 10.1007/s11274-021-03109-z.

Novel Drug Delivery Systems for Loading of Natural Plant Extracts and Their Biomedical Applications.

Rahman H, Othman H, Hammadi N, Yeap S, Amin K, Samad N Int J Nanomedicine. 2020; 15:2439-2483.

PMID: 32346289 PMC: 7169473. DOI: 10.2147/IJN.S227805.

References

Chen B, Yin L, Cheng J, Ding J, Gao C, Sun Y . Effect of D, L-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol and tetrandrine on the reversion of multidrug resistance in K562/A02 cells. Hematology. 2011; 16(1):24-30. DOI: 10.1179/102453311X12902908411797. View

Khalid M, Simard P, Hoarau D, Dragomir A, Leroux J . Long circulating poly(ethylene glycol)-decorated lipid nanocapsules deliver docetaxel to solid tumors. Pharm Res. 2006; 23(4):752-8. DOI: 10.1007/s11095-006-9662-5. View

Bunjes H, Unruh T . Characterization of lipid nanoparticles by differential scanning calorimetry, X-ray and neutron scattering. Adv Drug Deliv Rev. 2007; 59(6):379-402. DOI: 10.1016/j.addr.2007.04.013. View

Xia H, Zhang Z, Jin X, Hu Q, Chen X, Jia X . A novel drug-phospholipid complex enriched with micelles: preparation and evaluation in vitro and in vivo. Int J Nanomedicine. 2013; 8:545-54. PMC: 3575161. DOI: 10.2147/IJN.S39526. View

Cai X, Luan Y, Jiang Y, Song A, Shao W, Li Z . Huperzine A-phospholipid complex-loaded biodegradable thermosensitive polymer gel for controlled drug release. Int J Pharm. 2012; 433(1-2):102-11. DOI: 10.1016/j.ijpharm.2012.05.009. View

Fricker G, Kromp T, Wendel A, Blume A, Zirkel J, Rebmann H . Phospholipids and lipid-based formulations in oral drug delivery. Pharm Res. 2010; 27(8):1469-86. DOI: 10.1007/s11095-010-0130-x. View

Peltier S, Oger J, Lagarce F, Couet W, Benoit J . Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded lipid nanocapsules. Pharm Res. 2006; 23(6):1243-50. DOI: 10.1007/s11095-006-0022-2. View

Takemura H, Imoto K, Ohshika H, Kwan C . Tetrandrine as a calcium antagonist. Clin Exp Pharmacol Physiol. 1996; 23(8):751-3. DOI: 10.1111/j.1440-1681.1996.tb01772.x. View

Lamprecht A, Saumet J, Roux J, Benoit J . Lipid nanocarriers as drug delivery system for ibuprofen in pain treatment. Int J Pharm. 2004; 278(2):407-14. DOI: 10.1016/j.ijpharm.2004.03.018. View

10.

Liu Y, Wang P, Sun C, Feng N, Zhou W, Yang Y . Wheat germ agglutinin-grafted lipid nanoparticles: preparation and in vitro evaluation of the association with Caco-2 monolayers. Int J Pharm. 2010; 397(1-2):155-63. DOI: 10.1016/j.ijpharm.2010.06.030. View

11.

Thanki K, Gangwal R, Sangamwar A, Jain S . Oral delivery of anticancer drugs: challenges and opportunities. J Control Release. 2013; 170(1):15-40. DOI: 10.1016/j.jconrel.2013.04.020. View

12.

Liu Y, Pan J, Feng S . Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance. Int J Pharm. 2010; 395(1-2):243-50. DOI: 10.1016/j.ijpharm.2010.05.008. View

13.

Lamprecht A, Bouligand Y, Benoit J . New lipid nanocapsules exhibit sustained release properties for amiodarone. J Control Release. 2002; 84(1-2):59-68. DOI: 10.1016/s0168-3659(02)00258-4. View

14.

Cheng X, Liu R, He Y . A simple method for the preparation of monodisperse protein-loaded microspheres with high encapsulation efficiencies. Eur J Pharm Biopharm. 2010; 76(3):336-41. DOI: 10.1016/j.ejpb.2010.07.013. View

15.

Tan Q, Liu S, Chen X, Wu M, Wang H, Yin H . Design and evaluation of a novel evodiamine-phospholipid complex for improved oral bioavailability. AAPS PharmSciTech. 2012; 13(2):534-47. PMC: 3364372. DOI: 10.1208/s12249-012-9772-9. View

16.

Li S, Ji Z, Zou M, Nie X, Shi Y, Cheng G . Preparation, characterization, pharmacokinetics and tissue distribution of solid lipid nanoparticles loaded with tetrandrine. AAPS PharmSciTech. 2011; 12(3):1011-8. PMC: 3167269. DOI: 10.1208/s12249-011-9665-3. View

17.

Heurtault B, Saulnier P, Pech B, Proust J, Benoit J . A novel phase inversion-based process for the preparation of lipid nanocarriers. Pharm Res. 2002; 19(6):875-80. DOI: 10.1023/a:1016121319668. View

18.

Peng Q, Zhang Z, Gong T, Chen G, Sun X . A rapid-acting, long-acting insulin formulation based on a phospholipid complex loaded PHBHHx nanoparticles. Biomaterials. 2011; 33(5):1583-8. DOI: 10.1016/j.biomaterials.2011.10.072. View

19.

Peng Q, Zhang Z, Sun X, Zuo J, Zhao D, Gong T . Mechanisms of phospholipid complex loaded nanoparticles enhancing the oral bioavailability. Mol Pharm. 2010; 7(2):565-75. DOI: 10.1021/mp900274u. View

20.

Wu J, Chen D, Zhang R . Study on the bioavailability of baicalin-phospholipid complex by using HPLC. Biomed Chromatogr. 1999; 13(7):493-5. DOI: 10.1002/(SICI)1099-0801(199911)13:7<493::AID-BMC915>3.0.CO;2-A. View